(Q43268940)

17 November 2017

title

Validation of the adult ADHD investigator symptom rating scale (AISRS). (English)

1 reference

adult attention deficit hyperactivity disorder

17 November 2017

main subject

1 reference

Thomas J Spencer

1

1 reference

17 November 2017

Lenard A Adler

2

1 reference

17 November 2017

Meihua Qiao

3

1 reference

17 November 2017

Keith E Saylor

4

1 reference

17 November 2017

Thomas E Brown

5

1 reference

17 November 2017

James A Holdnack

6

1 reference

17 November 2017

Kory J Schuh

7

1 reference

17 November 2017

Paula T Trzepacz

8

1 reference

17 November 2017

Douglas K Kelsey

9

1 reference

17 November 2017

publication date

30 September 2009

1 reference

Journal of Attention Disorders

17 November 2017

published in

1 reference

17 November 2017

volume

14

1 reference

17 November 2017

issue

1

1 reference

17 November 2017

page(s)

57-68

1 reference

Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Training raters to assess adult ADHD: reliability of ratings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

A double-blind comparison of galantamine hydrogen bromide and placebo in adults with attention-deficit/hyperactivity disorder: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Coefficient alpha and the internal structure of tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Treating common psychiatric disorders associated with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

A concordance correlation coefficient to evaluate reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Guidelines for measurement validation in clinical trial design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Comorbidities and costs of adult patients diagnosed with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

Health status measures: strategies and analytic methods for assessing change scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1087054709347435

21 January 2018

Identifiers

DOI

10.1177/1087054709347435

1 reference

17 November 2017

1 reference